Skip to main content

Arcturus Therapeutics Holdings Inc 8-K, filed Nov 16, 2026

Arcturus Therapeutics Holdings Inc. (ARCT)

8-K 2026-11-16 For: 2026-11-16
View Original
Added on November 16, 2026

About this 8-K

Arcturus Therapeutics Holdings Inc filed this 8-K on November 16, 2026.

Arcturus sold 2,466,395 shares to Meiji for $50.0 million at an 80% premium, alongside an ARCT-154 license and a nonbinding MOU covering pandemic preparedness in Japan. AI summary

Items reported

  • Item 1.01: Entered into a material agreement
  • Item 3.02: Unregistered sale of equity
  • Item 7.01: Regulation FD disclosure
  • Item 9.01: Financial statements and exhibits